NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-046-2018-2-PCT-01 AUTOPHAGY INDUCERS FOR TREATMENT OF CNS CONDITIONS PCT PCT COMB PCT/US2018/015293 Expired
NCI E-244-2015-0-IL-07 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use IL National Stage 257127 Issued
NCI E-171-2018-7-IL-04 MODIFIED CELLS AND METHODS OF THERAPY IL National Stage 257105 Issued
NINDS E-088-2018-0-TW-04 Anti-HERV-K Envelope Antibody And Uses Thereof TW ORD 107102219 Issued
NEI E-284-2012-2-US-07 METHODS AND COMPOSITIONS FOR TREATING GENETICALLY LINKED DISEASES OF THE EYE US CON 15/876,821 1035-03-06 Issued PDF
NHLBI E-134-2017-3-JP-11 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 JP National Stage 2019-539809 Issued
NHLBI E-134-2017-3-NZ-14 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 NZ National Stage 755599 Issued
NHLBI E-134-2017-3-AU-03 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 AU National Stage 2018210404 Issued
NHLBI E-134-2017-3-PCT-01 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 PCT PCT COMB PCT/US2018/014532 Expired
NINDS E-088-2018-1-PCT-01 Amti-HERV-K Envelope Antibody and Uses Thereof PCT PCT COMB PCT/US2018/014489 Expired
NINDS E-088-2018-1-CN-04 Amti-HERV-K Envelope Antibody and Uses Thereof CN National Stage 201880014059.2 Pending
NHLBI E-134-2017-3-EP-08 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 EP National Stage 18742118.5 Pending
NINDS E-088-2018-1-EP-06 Amti-HERV-K Envelope Antibody and Uses Thereof EP National Stage 18713060.4 Pending
NINDS E-088-2018-1-IL-07 Amti-HERV-K Envelope Antibody and Uses Thereof IL National Stage 267955 Pending
NINDS E-088-2018-0-AR-02 Anti-HERV-K Envelope Antibody And Uses Thereof AR ORD 180100129 Pending
NINDS E-088-2018-1-JP-08 Amti-HERV-K Envelope Antibody and Uses Thereof JP National Stage 2019-539822 Pending
NINDS E-088-2018-1-KR-09 Amti-HERV-K Envelope Antibody and Uses Thereof KR National Stage 10-2019-7024261 Pending
NHLBI E-134-2017-3-KR-12 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 KR National Stage 10-2019-7024024 Pending
NHLBI E-134-2017-3-SG-15 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 SG National Stage 11201906422V Pending
NHLBI E-134-2017-3-ZA-16 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 ZA National Stage 2019/04733 Pending
NHLBI E-134-2017-3-MX-13 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 MX National Stage MX/a/2019/008529 Pending
NINDS E-088-2018-1-MX-10 Amti-HERV-K Envelope Antibody and Uses Thereof MX National Stage MX/a/2019/008648 Pending
NINDS E-088-2018-1-CA-03 Amti-HERV-K Envelope Antibody and Uses Thereof CA National Stage 3050286 Pending
NHLBI E-134-2017-3-CA-05 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 CA National Stage 3050106 Pending
NHLBI E-134-2017-3-CN-06 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 CN National Stage 2018800196047 Pending
NHLBI E-134-2017-2-TW-01 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 TW ORD 107102123 Pending
NINDS E-088-2018-1-UA-11 Amti-HERV-K Envelope Antibody and Uses Thereof UA National Stage a201909194 Pending
NHLBI E-134-2017-3-EA-07 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 EA National Stage 201991491 Pending
NINDS E-088-2018-1-EA-05 Amti-HERV-K Envelope Antibody and Uses Thereof EA National Stage 201991736 Pending
NHLBI E-134-2017-3-BR-04 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 BR National Stage BR1120190147071 Pending
NINDS E-088-2018-1-AU-02 Amti-HERV-K Envelope Antibody and Uses Thereof AU National Stage 2018210388 Pending
NHLBI E-134-2017-3-HK-21 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 HK EP 62020008181.3 Pending
NHLBI E-134-2017-3-IL-09 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 IL National Stage 268093 Pending
NHLBI E-134-2017-3-IN-10 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 IN National Stage 201917032726 Pending
NIA E-205-2006-2-US-26 PREPARATION OF (R,R)-FENOTEROL AND (R,R)- OR (R,S)-FENOTEROL ANALOGUES AND THEIR USE IN TREATING CONGESTIVE HEART FAILURE US CON 15/874,747 10308591 Issued PDF
NIAMS E-073-2011-2-US-02 ANTIBODIES THAT BIND TO TL1A AND METHODS OF TREATING INFLAMMATORY OR AUTOIMMUNE DISEASE COMPRISING ADMINISTERING SUCH ANTIBODIES US DIV 15/872,592 1059-02-01 Issued PDF
NCI E-251-2015-0-US-03 OPTICAL TRAP FOR RHEOLOGICAL CHARACTERIZATION OF BIOLOGICAL MATERIALS US National Stage 15/744,672 10459212 Issued PDF
NCATS E-020-2016-0-US-08 Antifungal Compound Process US CON 15/868,784 Pending
NCATS E-257-2010-0-MX-17 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators MX DIV MX/a/2018/000385 Issued
NCI E-094-2017-0-EP-01 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment EP DIV 21160649.6 Issued
NCI E-094-2017-0-EP-06 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment EP National Stage 18713034.9 Issued
NCI E-094-2017-0-CA-04 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment CA National Stage 3049252 Issued
NCI E-094-2017-0-AU-03 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment AU National Stage 2018205372 Issued
NCI E-094-2017-0-JP-07 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment JP National Stage 2019-537127 Issued
NIAID E-285-2002-0-US-28 LUTZOMYIA LONGIPALPIS POLYPEPTIDES AND METHODS OF USE US CON 15/866,050 10314900 Expired PDF
NCI E-094-2017-2-US-02 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment US ORD 15/866,222 10183993 Issued PDF
NCI E-094-2017-2-PCT-01 FULLY HUMAN ANTIBODIES THAT BIND HUMAN MESOTHELIN AND METHODS OF THEIR USE PCT PCT COMB PCT/US2018/012899 Expired
NCI E-094-2017-0-PCT-02 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment PCT PCT PCT/US2018/012954 Expired
NCI E-094-2017-0-CN-05 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment CN National Stage 201880015253.2 Pending
NIAID E-103-2014-3-US-08 Antibody Evolution Immunogens US CON 15/864,822 10849970 Issued PDF